Rapid dynamics of polyomavirus type BK in renal transplant recipients

被引:76
作者
Funk, GA
Steiger, J
Hirsch, HH
机构
[1] Univ Basel, Dept Clin & Biol Sci, CH-4003 Basel, Switzerland
[2] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
关键词
D O I
10.1086/498530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Polyomavirus type BK-associated nephropathy (PVAN) is an emerging cause of early renal transplant failure. No specific antiviral treatment has been established. Current interventions rely on improving immunefunctions by reducing immunosuppression. In patients with PVAN, a high BK virus (BKV) load is detectable in plasma. However, the relationship between BKV replication and disease is not well understood. Methods. In a retrospective analysis of BKV plasma load in renal transplant recipients undergoing allograft nephrectomy (n = 3) or changes in immunosuppressive regimen (n = 12), we calculated viral clearance rates and generation times and estimated the loss of BKV- infected renal cells. Results. After nephrectomy, BKV clearance was fast (viral half-life [t(1/2)], 1-2 h) or moderately fast (t(1/2), 20 38 h), depending on the sampling density, but it was independent of continued immunosuppressive regimens. After changing immunosuppressive regimens, BKV was cleared with a t(1/2) of 6 h-17 days. Using the basic reproductive ratio, the efficacies of intervention ranged from 7% to 83% (mean, 28%; median, 22%). Conclusion. The results emphasize that high-level BKV replication is a major pathogenetic factor that may have implications for genome rearrangements, immune evasion, and antiviral resistance.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 25 条
[1]  
ANDERSON R M, 1991
[2]   Polyomavirus BK-specific immunity after kidney transplantation [J].
Comoli, P ;
Azzi, A ;
Maccario, R ;
Basso, S ;
Botti, G ;
Basile, G ;
Fontana, L ;
Labirio, M ;
Cometa, A ;
Poli, F ;
Perfumo, F ;
Locatelli, F ;
Ginevri, F .
TRANSPLANTATION, 2004, 78 (08) :1229-1232
[3]   Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load [J].
Drachenberg, CB ;
Papadimitriou, JC ;
Hirsch, HH ;
Wali, R ;
Crowder, C ;
Nogueira, J ;
Cangro, CB ;
Mendley, S ;
Mian, A ;
Ramos, E .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2082-2092
[4]   The dynamics of human cytomegalovirus replication in vivo [J].
Emery, VC ;
Cope, AV ;
Bowen, EF ;
Gor, D ;
Griffiths, PD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) :177-182
[5]   Effect of leflunomide and cidofovir on replication of BK-virus in an in vitro culture system [J].
Farasati, NA ;
Shapiro, R ;
Vats, A ;
Randhawa, P .
TRANSPLANTATION, 2005, 79 (01) :116-118
[6]   BK virus nephropathy - Polyomavirus adding insult to injury [J].
Fishman, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :527-530
[7]  
Funk GA, 2001, J ACQ IMMUN DEF SYND, V26, P397, DOI 10.1097/00126334-200104150-00001
[8]  
Herrmann E, 2000, ANTIVIR THER, V5, P85
[9]   BK virus: Opportunity makes a pathogen [J].
Hirsch, HH .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :354-360
[10]   Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations [J].
Hirsch, HH ;
Brennan, DC ;
Drachenberg, CB ;
Ginevri, F ;
Gordon, J ;
Limaye, AP ;
Mihatsch, MJ ;
Nickeleit, V ;
Ramos, E ;
Randhawa, P ;
Shapiro, R ;
Steiger, J ;
Suthanthiran, M ;
Trofe, J .
TRANSPLANTATION, 2005, 79 (10) :1277-1286